These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression. Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402 [TBL] [Abstract][Full Text] [Related]
4. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway. Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955 [TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-4-induced epithelial-mesenchymal transition and invasiveness through Smad1-mediated signal pathway in squamous cell carcinoma of the head and neck. Xu T; Yu CY; Sun JJ; Liu Y; Wang XW; Pi LM; Tian YQ; Zhang X Arch Med Res; 2011 Feb; 42(2):128-37. PubMed ID: 21565626 [TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic proteins induce pancreatic cancer cell invasiveness through a Smad1-dependent mechanism that involves matrix metalloproteinase-2. Gordon KJ; Kirkbride KC; How T; Blobe GC Carcinogenesis; 2009 Feb; 30(2):238-48. PubMed ID: 19056927 [TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic proteins enhance an epithelial-mesenchymal transition in normal airway epithelial cells during restitution of a disrupted epithelium. McCormack N; Molloy EL; O'Dea S Respir Res; 2013 Mar; 14(1):36. PubMed ID: 23509993 [TBL] [Abstract][Full Text] [Related]
8. BMP4 Regulates EMT to be Involved in non-Syndromic Cleft lip With or Without Palate. Hong JW; Yu Y; Wang LS; Li Z; Zhang R; Wang Q; Ding Z; Zhang JP; Zhang MR; Xu LC Cleft Palate Craniofac J; 2023 Nov; 60(11):1462-1473. PubMed ID: 35702016 [TBL] [Abstract][Full Text] [Related]
10. BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Buijs JT; Rentsch CA; van der Horst G; van Overveld PG; Wetterwald A; Schwaninger R; Henriquez NV; Ten Dijke P; Borovecki F; Markwalder R; Thalmann GN; Papapoulos SE; Pelger RC; Vukicevic S; Cecchini MG; Löwik CW; van der Pluijm G Am J Pathol; 2007 Sep; 171(3):1047-57. PubMed ID: 17724140 [TBL] [Abstract][Full Text] [Related]
11. Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis. Verschueren PC; Lories RJ; Daans M; Théate I; Durez P; Westhovens R; Luyten FP Ann Rheum Dis; 2009 Jan; 68(1):117-23. PubMed ID: 18276742 [TBL] [Abstract][Full Text] [Related]
12. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871 [TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic proteins. Chen D; Zhao M; Mundy GR Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726 [TBL] [Abstract][Full Text] [Related]
14. Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition. Qiao B; Johnson NW; Chen X; Li R; Tao Q; Gao J Oncol Rep; 2011 Aug; 26(2):455-61. PubMed ID: 21567100 [TBL] [Abstract][Full Text] [Related]
15. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway. Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788 [TBL] [Abstract][Full Text] [Related]
16. Gemigliptin Inhibits Interleukin-1β-Induced Endothelial-Mesenchymal Transition via Canonical-Bone Morphogenetic Protein Pathway. Hong OK; Lee SS; Yoo SJ; Lee MK; Kim MK; Baek KH; Song KH; Kwon HS Endocrinol Metab (Seoul); 2020 Jun; 35(2):384-395. PubMed ID: 32615723 [TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362 [TBL] [Abstract][Full Text] [Related]
19. Functional characterization of bone morphogenetic protein binding sites and Smad1/5 activation in human vascular cells. Upton PD; Long L; Trembath RC; Morrell NW Mol Pharmacol; 2008 Feb; 73(2):539-52. PubMed ID: 17989347 [TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Na YR; Seok SH; Kim DJ; Han JH; Kim TH; Jung H; Lee BH; Park JH Cancer Sci; 2009 Nov; 100(11):2218-25. PubMed ID: 19735263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]